Absci Earnings
NASDAQ: ABSIHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
10.16+1.22 (+13.65%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Absci earnings summary
In its most recent report on Aug 11, 2026 (Q2 2026), ABSI posted EPS of $-0.21. Revenue for the quarter was $318,000. Across the last 16 reports, ABSI shares moved an average of 10.4% (in either direction) in the first trading session after results, rising 6 times and falling 9 times.
Summary generated from market data by MetaCap's automated system. Methodology
ABSI earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 11, 2026 | — | $-0.21 | — | +4.0% |
| May 7, 2026 | — | $-0.19 | — | -13.1% |
| Mar 24, 2026 | — | $-0.19 | — | +10.1% |
| Nov 12, 2025 | — | $-0.20 | — | +3.9% |
| Aug 12, 2025 | — | $-0.24 | — | -10.2% |
| May 13, 2025 | — | $-0.21 | — | -7.6% |
| Mar 18, 2025 | — | $-0.26 | — | -10.3% |
| Nov 12, 2024 | — | $-0.24 | — | -9.9% |
| Aug 14, 2024 | — | $-0.22 | — | +12.0% |
| May 14, 2024 | — | $-0.22 | — | -8.8% |
| Mar 21, 2024 | — | $-0.25 | — | +14.7% |
| Nov 14, 2023 | — | $-0.24 | — | -0.7% |
| Aug 14, 2023 | — | $-0.45 | — | 0.0% |
| May 15, 2023 | — | $-0.26 | — | +23.0% |
| Mar 30, 2023 | — | $-0.20 | — | -1.1% |
| Nov 9, 2022 | — | $-0.30 | — | -36.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.